MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Is levodopa-induced dyskinesia in Parkinson’s disease associated with increased blood brain barrier permeability and volumetric changes?

O. Segal, D. Last, D. Guez, Y. Mardor, G. Yahalom, O.S. Cohen, S. Benizri, C. Hoffman, S. Hassin-Baer (Ramat Gan, Israel)

Meeting: 2016 International Congress

Abstract Number: 857

Keywords: Dyskinesias, Levodopa(L-dopa), Magnetic resonance imaging(MRI), Parkinsonism

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The aim of this study was to explore the angiogenetic hypothesis for Levodopa-induced-dyskinesia (LID) using advanced MRI methods in patients with Parkinson’s disease (PD).

Background: The neural basis for the development of LID in PD involves abnormal neuroplastic changes originating in the striatum. Angiogenesis and increased permeability of the blood-brain barrier (BBB) have been reported to occur in animal models of PD and LID. A novel MRI methodology based on delayed contrast extravasation was developed for depicting BBB function through delayed-enhancement-subtraction-maps, with high resolution and sensitivity to changes.

Methods: Levodopa-treated PD patients that developed LID (LID+) were matched (1:1) according to age, gender and levodopa treatment duration to patients that had not developed LID (LID-). Motor symptoms and LID were rated and high resolution 3D FSPGR MRI images were obtained and analyzed using segmentation software that calculates volumes of pre-determined brain structures; these were integrated with the BBB maps, and the mean intensity was calculated for each structure, reflecting its BBB function. Comparison tests were made between the LID+ and LID- pairs and within patients between predominantly affected and less affected hemisphere.

Results: Preliminary results obtained from 9 matched pairs are presented. We could not demonstrate a statistically significant difference in BBB permeability or volumetric measurements of several brain structures between LID+ and LID- matched pairs; neither were there differences between the predominantly affected to the less affected hemisphere within patients.

Conclusions: The preliminary results of our in-vivo study, assessing BBB permeability along with volumetric changes in PD patients treated with L-dopa, failed to show an association between these measures and LID, and thus did not support the angiogenetic theory. The limitations of the study include the small number of patients recruited and initial data analyzed, but it is also possible that the MRI method is not sensitive enough to detect subtle BBB permeability changes. Further studies exploring the angiogenetic theory in PD-LID should be pursued using validated methods for detecting subtle BBB permeability changes and including larger number of patients.

Annual Meeting of the Israel Neurological Association, 2015.

To cite this abstract in AMA style:

O. Segal, D. Last, D. Guez, Y. Mardor, G. Yahalom, O.S. Cohen, S. Benizri, C. Hoffman, S. Hassin-Baer. Is levodopa-induced dyskinesia in Parkinson’s disease associated with increased blood brain barrier permeability and volumetric changes? [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/is-levodopa-induced-dyskinesia-in-parkinsons-disease-associated-with-increased-blood-brain-barrier-permeability-and-volumetric-changes/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/is-levodopa-induced-dyskinesia-in-parkinsons-disease-associated-with-increased-blood-brain-barrier-permeability-and-volumetric-changes/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley